• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 916 páginas
Examen

Katzung's Basic and Clinical Pharmacology 16th Edition Test Bank – Chapter-by-Chapter Exam Prep

Document preview thumbnail
Vista previa 4 fuera de 916 páginas

Katzung's Basic and Clinical Pharmacology 16th Edition Test Bank – Chapter-by-Chapter Exam Prep SEO Description Master pharmacology with this comprehensive Katzung's Basic and Clinical Pharmacology, 16th Edition Test Bank featuring chapter-by-chapter exam preparation. Strengthen clinical judgment using NCLEX® and NGN-style questions, SATA items, medication therapy case studies, and evidence-based pharmacotherapy scenarios. Review drug mechanisms of action, pharmacokinetics, pharmacodynamics, prototype medications, therapeutic uses, adverse drug reactions, contraindications, precautions, drug interactions, medication administration, monitoring, patient education, pharmacogenomics, medication safety, dosage calculations where applicable, and detailed answer rationales spanning cardiovascular, autonomic, endocrine, respiratory, gastrointestinal, neurologic, psychiatric, antimicrobial, anticancer, immunologic, and toxicology pharmacology. SEO Keywords Katzung's Basic and Clinical Pharmacology 16th Edition Test Bank Katzung 16th Edition Chapter-by-Chapter Exam Prep NCLEX Pharmacology Practice Questions and NGN Review Pharmacokinetics and Pharmacodynamics Exam Questions Medication Safety and Evidence-Based Pharmacotherapy Nursing Pharmacology Test Bank with Clinical Judgment Drug Mechanisms of Action and Pharmacotherapy Review

Vista previa del contenido

KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH




TEST BANK

,Question 1
A nurse is teaching a community group about the stages of
medication development. Which statement by a participant
indicates correct understanding of a phase III clinical trial?
A. "The drug is first tested in laboratory animals to determine
toxicity."
B. "The medication is evaluated in a small group of healthy
volunteers for basic safety."
C. "The drug is compared with current treatments in a large
population to assess effectiveness and adverse effects."
D. "The medication is monitored only after it has been removed
from the market."
Correct Answer: C
Rationale:
Phase III trials involve large groups of participants and compare
a new treatment with existing therapies or placebo to evaluate
efficacy, safety, and common adverse effects before regulatory
approval. Option A describes preclinical testing. Option B
describes phase I trials. Option D does not reflect post-
marketing surveillance, which occurs after approval and not
after removal from the market.
Question 2

,A nurse administers a medication that binds to receptors and
produces a maximal biological response. Which pharmacologic
property is best demonstrated?
A. Potency
B. Efficacy
C. Bioavailability
D. Clearance
Correct Answer: B
Rationale:
Efficacy refers to the maximum effect a drug can produce,
regardless of dose. Potency describes the amount of drug
required to produce a given effect. Bioavailability concerns the
fraction of administered drug reaching systemic circulation.
Clearance refers to the body's ability to eliminate the drug.
Question 3
A patient asks why two medications that treat the same
condition are prescribed at different doses. Which nursing
response is most accurate?
A. "The medication requiring the smaller dose is always safer."
B. "Drugs differ in potency, so different amounts may be needed
to achieve similar effects."

, C. "The higher-dose medication remains in the body for a
shorter time."
D. "Only generic medications require larger doses."
Correct Answer: B
Rationale:
Potency reflects the amount of drug needed to achieve a
specific effect. Two medications with equal efficacy may require
different doses because of differences in receptor affinity or
pharmacologic properties. A smaller dose does not
automatically mean greater safety. Duration of action and
generic status are unrelated to potency.
Question 4
A nurse reviews a prescription for a medication with a narrow
therapeutic index. Which action is most important?
A. Administer the medication without laboratory monitoring.
B. Double the dose if symptoms persist.
C. Monitor drug levels and assess for signs of toxicity.
D. Instruct the patient to stop the medication if one dose is
missed.
Correct Answer: C
Rationale:

Libro relacionado
 image
Editorial: 2023 ISBN: 9781260463309 Edición: Desconocido

Información del documento

Subido en
4 de julio de 2026
Número de páginas
916
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$37.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
0
Seguidores
0
Artículos
34
Última venta
-



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes